Integrated QC dashboard and unlimited validation cycles for interim and final datasets creates industry’s most user-friendly validator
PointCross Logo
FOSTER CITY, Calif., July 20, 2022 (GLOBE NEWSWIRE) — PointCross Life Sciences announced today the full complement release of its eDataValidator™ (eDV) for validating SDTM, ADaM, SEND and Define.XML data for conformance to prevailing FDA, CDISC, and PMDA rules.
Used by 5 of the top 10 large pharma as part of the Xbiom™ regulatory suite, eDV is now available as a standalone tool in response to calls from Sponsor clinical operations, biostatisticians and biometrics communities. Industry called for easily accessible, cheaper tools that work well for qualified workflows for data standardization to SDTM – and analysis datasets in ADaM – in incremental stages until the final packaging for submission.
eDV offers limitless validation of Clinical SDTM as well as Nonclinical SEND, making this a single solution for IND, NDA and BLA preparation.
With eDataValidator, users can:
PointCross Life Sciences offers several types of configurations to deploy its eDV. Each of these configurations have very competitively priced, optional support, integration and validation services.
eDataValidator simplifies the validation experience with a built in QC dashboard to review and verify reported issues/non-conformities, and easy comparisons of datasets across loaded versions. Users can generate Define files, TS.XPT, and easily convert XPT files to Excel (useful for the nonclinical user community spot-checking SEND datasets).
About PointCross Life Sciences
PointCross Life Sciences, founded in 2010 in the San Francisco Bay Area, is a privately held global technology company providing the Life Sciences industry with solutions in big data analytics, management, visualization, and warehousing. Powered by the Xbiom™ Insights and Regulatory platform, our offerings reduce risk and improve data quality, thus shortening time to market and generating better insights from both R&D and regulatory data for a globally dispersed number of CROs, large pharma, and small biotechnology Sponsors. For more information, please visit www.pointcross.com
Press Contact:
Kunaal Madhavan
Marketing at PointCross Life Sciences
kunaal@pointcross.com
Related Images
This content was issued through the press release distribution service at Newswire.com.
Attachment
PALO ALTO, Calif., Nov. 22, 2024 /PRNewswire/ -- Aulisa® Medical USA, Inc., a leader in…
NEW YORK, Nov. 22, 2024 /PRNewswire/ -- Report on how AI is redefining market landscape -…
Vancouver, British Columbia--(Newsfile Corp. - November 22, 2024) - DEFENCE THERAPEUTICS INC. (CSE: DTC) (OTCQB:…
3,250 InsuJet Starter Packs Being Delivered to Pharmacies Across CanadaToronto, Ontario--(Newsfile Corp. - November 22,…
The new app allows users to browse services, book IV therapy, manage appointments, purchase packages,…
PHILADELPHIA, Nov. 22, 2024 /PRNewswire/ -- Independence Blue Cross (IBX) is implementing the Epic Payer Platform…